details. in that statement she says mauricio garcia entered the regular army in june 2008. he was terminated three months later without completing initial entry training. he was not awarded a military occupational specialty. he had no deployments or awards. we do not provide characterization of discharge for any soldier and according to an army official, he was separated under the 2005 edition of army regulation 635-200, paragraph 517. other designated physical or mental condition. so reported in various places earlier, this is now official and according to a u.s. army public affairs spokesperson just a few moments ago as we learn more about the shooter that deadly rampage on saturday at a texas outlet mall. we ll have more for you coming up. are you prepared to evoke the
SAN FRANCISCO, CA / ACCESSWIRE / May 5, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective May 2, 2023, the Company granted 100 restricted stock units
that went on to the lawyers and the personalities. and he determined that the oklahoma city bombing case was going to be very different. and he made sure that the case was tried only in the courtroom. he is now in a very different place. he s now the attorney general. but he has the same attitude toward publicity. he doesn t want to call attention to things unless it is an actual court case. and i think that is that is unfortunate. i think as attorney general, you have a platform where he could call out the continuing danger of right-wing extremism in this country. he hasn t done it to the degree he could. the. look, it s a fascinating read. you went to the university of texas where the lead attorney for mcveigh donated all the documents, 635 boxes, a million documents. you found pethings that people
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted one newly-hired employee inducement options to purchase an aggregate
LEXINGTON, Mass. and AMSTERDAM, May 02, 2023(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the Company granted